Ventilator device distinctions in FDA guidance questioned by panel.
This article was originally published in The Gray Sheet
Executive Summary
FDA VENTILATOR GUIDANCE'S CRITICAL CARE USE DISTINCTION QUESTIONED by members of the agency's Anesthesiology and Respiratory Therapy Devices Panel at a Sept. 8 meeting in Rockville, Maryland. Commenting on the draft guideline's creation of a separate product code for continuous ventilators not intended for use in critical care settings, panel member Robert Kacmarek, PhD, Massachusetts General Hospital, Boston, said it seems "arbitrary to try to subcategorize those units and to believe that the medical community is going to, as a result, use ventilators that function equivalently in different settings simply" because they are labeled for use in those different settings.
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.